WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003072159) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)­-BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE COATED STENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/072159    International Application No.:    PCT/EP2003/002028
Publication Date: 04.09.2003 International Filing Date: 27.02.2003
Chapter 2 Demand Filed:    25.08.2003    
IPC:
A61K 31/502 (2006.01), A61L 29/16 (2006.01), A61L 31/16 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VC, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
PRESCOTT, Margaret, Forney [US/US]; (US) (For US Only).
FELDMAN, David, Louis [US/US]; (US) (For US Only)
Inventors: PRESCOTT, Margaret, Forney; (US).
FELDMAN, David, Louis; (US)
Agent: GROS, Florent; Novartis AG, Corporate Intellectual Property, CH-4002 Basel (CH)
Priority Data:
60/360,254 28.02.2002 US
Title (EN) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)­-BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE COATED STENTS
(FR) STENTS ENDUITS DE N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)--BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE
Abstract: front page image
(EN)The invention relates to the local administration of N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine or a pharmaceutically acceptable salt or crystal form thereof, optionally in conjunction with one or more other active ingredients, and a device adapted for such local administration.
(FR)L'invention concerne l'administration locale de N-{5-[4-(4-méthyl-pipérazino-méthyl)-benzoylamido]-2-méthylphényl}-4-(3-pyridyl)-2-pyrimidine-amine, d'un sel acceptable sur le plan pharmaceutique ou d'une forme cristalline de ce composé, éventuellement associés à un ou plusieurs autres principes actifs. L'invention concerne par ailleurs un dispositif conçu pour cette administration locale.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)